Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if CADL is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
29 top institutions tracked
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 34 days ago
Red flags: 2
138 filers reported a long position in CADL for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| FMR LLC | $113.2M | 11M | 0% |
| RTW INVESTMENTS, LP | $66.1M | 6.4M | Unchanged |
| BlackRock, Inc. | $51.2M | 5M | +59.8% |
| STATE STREET CORP | $36.6M | 3.5M | +333.7% |
| ACORN CAPITAL ADVISORS, LLC | $36M | 3.5M | Unchanged |
| Portolan Capital Management, LLC | $36M | 3.5M | +20.6% |
| Saturn V Capital Management LP | $34M | 3.3M | +14.1% |
| VANGUARD CAPITAL MANAGEMENT LLC | $27.7M | 2.7M | +9.4% |
| GEODE CAPITAL MANAGEMENT, LLC | $16.2M | 1.6M | +51.7% |
| MILLENNIUM MANAGEMENT LLC | $11.3M | 1.1M | +3.2% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.